Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2005
09/21/2005EP1575557A1 Process for the chemical stabilization of a solubilized retinoid in a solvent using a base
09/21/2005EP1575552A2 Metal-containing materials, compositions and methods
09/21/2005EP1575551A1 Nutritional supplement composition and method
09/21/2005EP1575545A2 Affinity proteins for controlled application of cosmetic substances
09/21/2005EP1575531A2 THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-&bgr;
09/21/2005EP1575519A2 Cd26-based therapies for cancers and immune disease
09/21/2005EP1575514A2 Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders
09/21/2005EP1575509A2 Epha2 agonistic monoclonal antibodies and methods of use thereof
09/21/2005EP1575508A2 Compositions and methods for the intracellular delivery of antibodies
09/21/2005EP1575504A2 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575496A2 Colon tumor specific binding peptides
09/21/2005EP1575494A2 Engineering absorption of therapeutic compounds via colonic transporters
09/21/2005EP1575414A2 Methods and devices for detection and therapy of atheromatous plaque
09/21/2005EP1542728A4 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same
09/21/2005EP1435965A4 Pharmaceutical compositions and methods for treating cancer
09/21/2005EP1404377B1 Improved chelator conjugates
09/21/2005EP1373546A4 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof
09/21/2005EP1355641B1 Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
09/21/2005EP1200115B1 Multi-dose erythropoietin formulations
09/21/2005EP1194174B1 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood
09/21/2005EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia
09/21/2005EP1087791B1 Inhibition of xenoreactive antibodies
09/21/2005EP1083861B1 Hydrous cosmetic or pharmaceutical sticks
09/21/2005EP1028756B1 Water soluble paclitaxel conjugates combined with irradiation for the treatment of cancer
09/21/2005EP1002065B1 Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations
09/21/2005EP0994710B2 Pharmaceutical compositions for oral administration, comprising a benzhydrylpiperazine and a cyclodextrin
09/21/2005EP0925065B1 Water miscible erythromycin compositions
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005CN1671863A Central airway administration for systemic delivery of therapeutics
09/21/2005CN1671782A Porous beads and method of production thereof
09/21/2005CN1671741A Buffered formulations for concentrating antibodies and methods of use thereof
09/21/2005CN1671735A Pegylated T1249 polypeptide
09/21/2005CN1671422A Polyalkylene glycol acid additives
09/21/2005CN1671421A Inclusion complexes of rosiglitazone
09/21/2005CN1671420A Pegylated factor VII glycoforms
09/21/2005CN1671419A A process for the preparation of piroxicam: beta-cyclodextrin inclusion compounds
09/21/2005CN1671418A Oral administration of calcitonin
09/21/2005CN1671412A Immunostimulatory compositions and methods of stimulating an immune response
09/21/2005CN1671409A Topical drug delivery using phosphatidylcholine
09/21/2005CN1671405A Antipyrotic and method of manufacturing the same
09/21/2005CN1671400A Compositions of hyaluronic acid and methods of use
09/21/2005CN1671397A Use of alkyl phosphocholines in combination with antitumor medicaments
09/21/2005CN1671396A Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient
09/21/2005CN1671393A Targeted oxidative therapeutic formulation
09/21/2005CN1671388A Sustained-release tablet composition comprising a dopamine receptor agonist
09/21/2005CN1671385A Parenteral formulations containing a rapamycin hydroxyester
09/21/2005CN1671383A Sustained-release tablet comprising reboxetine
09/21/2005CN1671382A Sustained-release tablet composition of pramipexole
09/21/2005CN1671376A Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent
09/21/2005CN1671375A Improved transdermal delivery system for the administration of rotigotine
09/21/2005CN1671370A Composition for solubilization of paclitaxel and preparation method thereof
09/21/2005CN1671367A Aqueous 2, 6-diisopropylphenol pharmaceutical compositions
09/21/2005CN1671365A Improved transdermal delivery system
09/21/2005CN1671363A Extended release formulation of divalproex sodium
09/21/2005CN1671362A Biodegradable block copolymeric compositions for drug delivery
09/21/2005CN1671361A Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
09/21/2005CN1671359A Chinese herb medicine composition in the form of jelly
09/21/2005CN1671358A Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
09/21/2005CN1671357A Short duration depot formulations
09/21/2005CN1671351A NSAID-containing topical formulations that demonstrate chemopreventive activity
09/21/2005CN1671344A Powder compaction and enrobing
09/21/2005CN1671287A Antimicrobial envelopes
09/21/2005CN1669551A Auxiliary materials of drop pills base material and manufacturing method of drop pills
09/21/2005CN1219549C Skin-permeated absorption-promoting agent and cosmetics thereof
09/21/2005CN1219520C External preparations for treating dermatitis
09/21/2005CN1219517C Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
09/21/2005CN1219514C Oral medicine preparation with high absorbency
09/21/2005CN1219512C Pharmaceutical compositions containing oxapenem-3-carboxylic acids
09/21/2005CN1219508C Mucilage antiseptic medicine composition capable of being locally administrated and sustainably released and its preparing method
09/21/2005CN1219449C Addition of tetracyclines to animal foodstuffs
09/20/2005US6946547 Via immunoassay; low cross-reactivity with ephedrine and other compounds; antibody produced by a methylene dioxyphenyl derivative of agiven structure
09/20/2005US6946436 Oil in water emulsions; mixture containing electrolyte, polyglycerol fatty acid ester, acrylic acid-alkyl methacrylate copolymer
09/20/2005US6946150 Lipophilic medicament, a solvent and a co-solvent in an amount > 55% wt/wt of the formulation; free from self emulsifying agent and/or a fluorinated propellant; cannabinoids administered by a pump action spray
09/20/2005US6946146 For forming controlled release formulation of a therapeutic agent; for coating solid dosage
09/20/2005US6946145 Block copolymers based on poly(ortho esters) containing amine groups
09/20/2005US6946144 Transdermal delivery system
09/20/2005US6946141 As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation
09/20/2005US6946137 Methods for the controlled delivery of pharmacologically active compounds
09/20/2005US6946135 Prevention and treatment of amyloidogenic disease
09/20/2005US6946127 Block exposure to nerve toxicity
09/20/2005US6946121 Composition in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
09/20/2005US6946120 For therapy of hair loss
09/20/2005US6946118 comprises tetracycline derivative that is poorly absorbed from the gastrointestinal tract; may include fungicide; side effect reduction; aersols; mouthwashes
09/20/2005CA2387607C Use of galactomannans as an emulsifying agent
09/20/2005CA2348869C Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
09/20/2005CA2304976C Delivery of poly(ethylene glycol)-conjugated molecules from degradable hydrogels
09/20/2005CA2089494C Vesicles in non-polar media
09/16/2005CA2500072A1 Improved method for drying neotame with co-agents
09/15/2005WO2005085458A2 Polyacetal-peptide mediated transfection
09/15/2005WO2005085457A2 Method and products for the selective degradation of proteins
09/15/2005WO2005085294A1 Hyaluronic acid/methotrexate compound
09/15/2005WO2005085283A1 Modified interleukin-11 and medicinal composition containing the same
09/15/2005WO2005084751A2 Implantable system for controlling gene expression
09/15/2005WO2005084715A2 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy
09/15/2005WO2005084713A2 Enzyme-prodrug therapy for prosthetic joint repair
09/15/2005WO2005084711A1 A pegylated recombinant erythropoietin that has in vivo activity
09/15/2005WO2005084704A1 Digestive bypass composition for arthropod and uses thereof
09/15/2005WO2005084703A1 Sustained-release composition for oral cavity
09/15/2005WO2005084682A1 Pharmaceutical composition comprising cyclodextrin complex of tibolone
1 ... 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 ... 1712